Human embryonic and induced pluripotent stem cells (hESCs and hiPSCs) are self-renewing human pluripotent stem cells (hPSCs) that can differentiate to a wide range of specialized cells. Notably, hPSCs enhance their undifferentiated state and self-renewal properties in hypoxia (5% O2). Although thoroughly analyzed, hypoxia implication in hPSCs death is not fully determined. In order to evaluate the effect of chemically mimicked hypoxia on hPSCs cell survival, we analyzed changes in cell viability and several aspects of apoptosis triggered by CoCl2 and dimethyloxalylglycine (DMOG). Mitochondrial function assays revealed a decrease in cell viability at 24 h post-treatments. Moreover, we detected chromatin condensation, DNA fragmentation and CASPASE-9 and 3 cleavages. In this context, we observed that P53, BNIP-3, and NOXA protein expression levels were significantly up-regulated at different time points upon chemical hypoxia induction. However, only siRNA-mediated downregulation of NOXA but not HIF-1α, HIF-2α, BNIP-3, and P53 did significantly affect the extent of cell death triggered by CoCl2 and DMOG in hPSCs. In conclusion, chemically mimicked hypoxia induces hPSCs cell death by a NOXA-mediated HIF-1α and HIF-2α independent mechanism.
Human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs) are self-renewing pluripotent stem cells (hPSCs) that can differentiate and give rise to all cell types derived from the three germ layers, endoderm, mesoderm and ectoderm. Particularly, hESCs are derived from the inner cell mass of the human blastocyst, at the early stages of embryonic development1. Instead, hiPSCs are reprogrammed from adult somatic cells for example by in vitro transfection of vectors encoding crucial pluripotency transcription factors (e.g. OCT-4, SOX-2, KLF-4 and c-MYC)2. Therefore, hPSCs hold great promise as models for the study of human development and disease, as well as for drug discovery and cell-replacement therapies1,3. However, although hPSCs can indefinitely proliferate in vitro they are endowed with a cell-intrinsic property termed mitochondrial priming that renders them highly sensitive to apoptotic stimuli4. Thus, all attempts to define the mechanisms that govern cell survival in hPSCs and their differentiating progeny could help to improve large-scale in vitro expansion of hPSCs, the generation of a safe transplantable cell source with minimal or no risk for tumor/teratoma formation, and the clinical outcome of therapies relying on hPSCs-derived cells.
Hypoxia is a pathophysiological condition which is accompanied by an increase in reactive oxygen species (ROS) thus provoking oxidative stress5. However, although hypoxia is thought to be a pathological phenomenon, embryonic tissues develop in a hypoxic environment at the early stages, until the cardiovascular and hematopoietic systems are sufficiently differentiated to provide oxygen for them6. Upon exposure to hypoxic conditions, cells mount a physiological response to ensure sufficient levels for oxygen-dependent processes. This adaptive response is mainly mediated through the activation of the oxygen-sensitive transcription factors, hypoxia-inducible factors (HIF-1α, HIF-2α/EPAS1 and HIF3-α). In normoxia, HIF-1α and HIF-2α undergo prolyl hydroxylation, which leads to specific binding to the ubiquitin E3 ligase Von Hippel-Lindau, polyubiquitination, and proteasomal degradation. However, HIF-1α and HIF-2α are stabilized in low oxygen levels, dimerize with HIF-1β, which is also known as aryl-hydrocarbon-receptor nuclear translocator, and fine-tune the transcription of target genes7,8.
Interestingly, in vitro exposure of hPSCs to reduced levels of oxygen (5%) favors the maintenance of the undifferentiated state, as well as promotes self-renewal and prevents spontaneous differentiation9,10,11. Despite this, hPSCs in vitro culture is still usually performed under ambient air (O2 concentration of approximately 21%) enriched with 5% CO2, given that modular hypoxia incubator chambers are not frequently available in many cell culture facilities. To overcome this limitation, chemical compounds that inhibit prolyl hydroxylase domain-containing enzymes, like cobalt chloride (CoCl2) and dimethyloxalylglycine (DMOG) can be used in vitro to mimic hypoxic conditions by stabilizing HIF-1α and generating ROS12,13,14. In this regard, until the present, the effects of chemical induced hypoxia on hPSCs viability have not been studied. It has been reported that in mouse embryonic stem cells (mESCs) CoCl2 induces apoptosis and necrosis through the mitochondria- and death receptor-mediated pathways12.
In the present work, we found that chemically mimicked acute hypoxic conditions, induced with CoCl2 and DMOG treatments, decreased hPSCs viability. Importantly, at 24 h post-chemical hypoxia induction we observed the appearance of apoptotic hallmarks such as cell ballooning and detachment, pyknotic hyperchromatic nuclei, prominent internucleosomal DNA fragmentation and caspases activation. Remarkably, cell death occurred independently of HIF-1α, HIF-2α and P53 expression levels. However, specific siRNA-mediated downregulation of the pro-apoptotic factor NOXA protected hPSCs from chemical hypoxia induced apoptosis. Collectively, herein we demonstrated that chemical hypoxia triggered apoptosis in hPSCs via a NOXA-mediated HIF-1α and HIF-2α independent mechanism.
Chemical hypoxia induced by CoCl2 and DMOG stabilizes HIF-1α in hPSCs
Hypoxia was induced in H9 hESCs and FN2.1 hiPSCs grown on Vitronectin coated cell culture dishes with fully defined Essential E8 medium (E8) by a chemical method. Particularly, we mimicked hypoxic conditions in hPSCs using the following chemicals: CoCl2 (250 µM for 24 h) and DMOG (1 mM for 24 h). Both treatments caused an increase in the intracellular levels of HIF-1α, which was analyzed by Western blot (Supplementary Fig. S1a). In the case of HIF-2α we determined basal expression levels that were not induced upon chemical hypoxia stimulus (Supplementary Fig. S1a). Moreover, hypoxic conditions were further validated by analyzing the mRNA expression levels of BCL2/adenovirus E1B 19 kDa interacting protein 3 (BNIP-3), a well-known transcriptional target of the HIF-1α/HIF-1β complex15 (Supplementary Fig. S1b). Interestingly, concentrations of CoCl2 as low as 50 µM were able to increase significantly BNIP-3 mRNA expression levels in H9 hESCs (Supplementary Fig. S1c).
Chemical hypoxia triggers apoptosis of hPSCs
We next wondered whether reduced levels of oxygen (5% O2) and chemical hypoxia induction affect hPSCs and human fibroblast (HF) viability. We included 5% O2 treatment as a direct comparator to the effects of DMOG or CoCl2 as long terms effects of cellular hypoxia (5% O2) proved to be beneficial to in vitro hESCs cell cultures. In addition, HF were used as an example of terminal differentiated cells and, particularly, the HF used were the ones from which hiPSCs line FN2.1 was reprogrammed. We determined the percentage of cell viability after 24 h incubation with 5% O2 and after 24 h of chemical hypoxia induction with increasing concentrations of CoCl2 and DMOG using a XTT/PMS vital dye assay. As shown in Fig. 1a, cell viability felt down significantly in H9 and FN2.1 cell lines with both compounds (CoCl2 and DMOG) while no significant changes were observed upon 5% O2 incubation. As expected, changes in cell viability were concentration dependent, and concentrations that reduced cell viability by 30–50% were chosen for further experiments (250 µM for CoCl2; 100 µM and 1 mM for DMOG). XTT assay is dependent on mitochondrial respiration, which is inhibited in a dose dependent manner by hypoxia-mimetic agents, for this reason we also measured cell viability by Trypan blue dye exclusion staining. Similar results were obtained when live and dead cells were counted using Trypan blue dye. As shown in Fig. 1b the percentage of surviving hPSCs (H9 and FN2.1) significantly decreased 24 h after CoCl2 (250 µM) and DMOG (1 mM) addition and no effect was found with 5% O2. As Trypan blue staining showed that DMOG 100 µM does not affect cell viability, 1 mM concentration was chosen for further experiments.
Additionally, we measured cell death by flow cytometry analysis of propidium iodide (PI) staining in H9, FN2.1 and HF cells. Histograms in Fig. 1c show the percentages of 5% O2−, CoCl2−, DMOG-treated or untreated cells exhibiting loss of plasma membrane integrity (late apoptosis or necrosis). We observed that only chemical hypoxia (CoCl2 250 µM and DMOG 1 mM, 24 h treatments) induced apoptosis or necrosis in hPSCs. Importantly, HF resulted in less sensitive or not sensitive to the cytotoxicity triggered by CoCl2 and DMOG at the tested concentrations than hPSCs (Fig. 1b,c).
Next, to elucidate whether the mode of cell death triggered by chemical hypoxia is via apoptosis we evaluated the appearance of apoptotic features in hESCs (H9) and hiPSCs (FN2.1). Importantly, as we observed no cell death induction, we stopped using 5% O2 treatment and HF as comparators. Chromatin condensation paralleled by ballooning and cell detachment are some of the criteria which are used to identify apoptotic cells. Therefore, we assessed these morphological changes by DAPI staining of nuclear DNA and bright-field microscopic images of cells subjected to chemical hypoxia or normoxia, respectively. We observed that chemical hypoxia (24 h treatment with CoCl2 250 µM and DMOG 1 mM) increased both the percentage of hESCs and hiPSCs exhibiting intense bright DAPI staining, indicative of apoptotic nuclei, (3.4 ± 0.5% Vehicle, 13.2 ± 1.1% CoCl2 250 µM and 21.1 ± 2.8% DMOG 1 mM for H9 cells; 4.5 ± 0.9% Vehicle, 30.6 ± 2.5% CoCl2 250 µM and 42.5 ± 4.9% DMOG 1 mM for FN2.1 cells), and the presence of ballooned and detached cells (Fig. 2a).
We next measured DNA fragmentation (cytoplasmic oligonucleosomal fragments of approximately 180–200 bp, or multiples of that, representative of inter-nucleosomal cleavage of DNA), a late event in the apoptotic cascade. We quantified DNA oligomers with an immunoassay, using antibodies directed against DNA and histones. As shown in Fig. 2b, a significant increase in the proportion of DNA oligomers was observed 24 h after CoCl2 (250 µM) and DMOG (1 mM) treatments in both H9 and FN2.1 cells.
Activation of initiator and effector caspases is other relevant criteria to determinate apoptosis. Upon chemical hypoxia induction, initiator pro-CASPASE-9 (47 kDa) was cleaved into active fragments (37/35 kDa), as judged by the decrease in pro-CASPASE-9 and the increase in active fragments levels detected by Western blot in H9 and FN2.1 cells (Fig. 3a). Cleaved CASPASE-9 can further process other caspase members, including CASPASE-3, to initiate a caspase cascade, which leads to apoptosis. Western blot detection of cleaved CASPASE-3 (appearance of p17 fragment) revealed a time-dependent activation of CASPASE-3, which was accompanied by HIF-1α stabilization and CASPASE-9 activation, mediated by CoCl2 (250 µM) and DMOG (1 mM) treatments (Fig. 3a). Moreover, CASPASE-3 activation was also confirmed by immunofluorescence in both cell lines as soon as 6 h after chemical hypoxia induction (Supplementary Fig. S2). In parallel, time course studies showed the presence of cleaved PARP (effector caspases substrate) which was preceded by the appearance of the catalytically active fragment p17. This chronology is compatible with the involvement of CASPASE-3 in PARP proteolysis (Fig. 3a and Supplementary Fig. S3). Importantly, we determined that chemical hypoxia induction resulted in the activation of apoptotic caspases with very similar kinetics in hiPSCs FN2.1 and hESCs H9. Interestingly, kinetics of HIF-1α stabilization was accelerated in both FN2.1 and H9 cells when DMOG was used at the tested concentration (Fig. 3a and Supplementary Fig. S3).
As a whole, the above results indicate that chemical hypoxia induces cell death mainly via apoptosis in hPSCs. Besides, based on the presence of cleaved CASPASE-9, the mitochondrial-mediated apoptosis pathway participates in this event.
Apoptotic protein profiling in chemical hypoxia-treated hPSCs
In order to gain further insights about the pathways and potential mechanisms by which chemical hypoxia may regulate apoptosis in hPSCs, we performed an exploratory experiment by screening 43 human apoptosis-related proteins using a human Apoptosis Antibody Array. In fact, H9 hESCs treated with CoCl2 (250 µM) for 8 h showed a changed expression profile of apoptosis-related proteins (Fig. 3b). Importantly, similarly as previously reported in Fig. 3a and Supplementary Fig. S2, we observed an enhanced active CASPASE-3 immunoreactivity in CoCl2-treated cells compared to Vehicle (H2O)-treated counterparts (Fig. 3b and Supplementary Fig. S4). Intriguingly, it came to our attention a marked reduction in CASPASE-8 signal that could be a cause of caspase proteolysis and activation due to extrinsic apoptosis pathway induction. This hypothesis was further reinforced by the increased expression levels observed of several apoptosis-related proteins involved in the extrinsic pathway, like TNF-α, sTNF-R2, IGFBP family, FAS and Death receptor 6 (DR6) (Fig. 3b and Supplementary Fig. S4). Moreover, in what respect to the mitochondria-mediated apoptosis pathway, changes in CYTOCHROME C and c-IAP-2 (both upregulated), as well as IGF-I, IGF-II, BIM, BCL-2 and BCL-w (all downregulated) were detected (Fig. 3b and Supplementary Fig. S4). Also, worth mentioning the strong downregulation of IGF-I and IGF-II, cytokines that by activating ERK1/2 and PI3K/AKT pathways turn out to be essential for hPSCs self-renewal and viability16,17,18.
hPSCs are very susceptible to undergo apoptosis due to their higher state of mitochondrial priming, a lowered cell intrinsic threshold for initiating mitochondrial induced apoptosis, based on the balance of pro- and anti-apoptotic protein members of the BCL-2 family19. Bearing this in mind, we next quantified key BCL-2 family members in hPSCs (not present in the Apoptosis Array) expression levels after chemical hypoxia induction. Particularly BCL-XL, a key anti-apoptotic protein; BNIP-3, a well-known pro-apoptotic protein which is induced upon hypoxic stimuli20; MCL-1 (anti-apoptotic), PUMA (pro-apoptotic) and NOXA (pro-apoptotic) which are highly expressed and rapidly responding proteins in hPSCs21,22. To address this issue, Western blot assays were performed to analyze expression levels of these BCL-2 family members in hPSCs at 4, 8 and 24 h post-chemical apoptosis induction with CoCl2 (250 µM) treatment. Results shown in Fig. 4a indicate that BNIP-3, MCL-1 and NOXA expression levels were significantly up-regulated at different time points upon chemical hypoxia induction. On the contrary, PUMA expression levels decreased at 24 h post-CoCl2 treatment. Moreover, these increments were also observed in BNIP-3, BNIP-3L (also known as NIX, which is a BNIP-3 homologue), MCL-1 and NOXA mRNA expression levels quantified by RT-qPCR (Supplementary Figs. S1 and S5).
P53 is a well characterized tumor suppressor transcription factor that gets activated by cellular stress events such as DNA damage and hypoxia, among others23. One of P53 functions is to induce transcription of genes that code for some proteins involved in the intrinsic pathway of apoptosis such as PUMA, NOXA and BAX24. In order to study the possible participation of P53 in our chemical model of hypoxia we first measured P53 levels by Western blot in H9 and FN2.1 cells treated with CoCl2 (250 µM) for 4, 8 and 24 h. Interestingly, we found out that P53 expression levels were significantly up-regulated at different time points in both cell lines (Fig. 4b). In consequence, P53 may participate in chemical hypoxia-induced apoptosis in hPSCs.
Involvement of HIF-1α and HIF-2α in chemical hypoxia-induced apoptosis in hPSCs.
Next, to test HIF-1α and HIF-2α involvement in chemical hypoxia-induced apoptosis in hPSCs, we used siRNA to downregulate both HIFs expression. The efficiency of siRNA- knockdown was monitored by RT-qPCR and Western blot in hESCs (H9) and hiPSCs (FN2.1) cultured in defined E8 medium and transfected with either non-targeting control siRNA (NT-siRNA) or specific siRNA. As shown in Fig. 5a,b, siRNA transfection led to a significant decrease in HIF-1α and HIF-2α mRNA and protein expression levels (in the case of HIF-1α, protein expression levels were knocked-down even in CoCl2-treated cells). Interestingly, we found that in hPSCs siRNA-mediated downregulation of both HIF-1α and HIF-2α was not able to revert the increased apoptosis or necrosis induced by chemical hypoxia (CoCl2 250 µM and DMOG 1 mM) as judged by PI staining and Trypan blue dye exclusion data (Fig. 5c,d and Supplementary Figs. S6 and S7). Taken together, the above results suggest that chemical hypoxia induces hPSCs cell death by a HIF-1α and HIF-2α independent mechanism. In this sense, we observed a strong inhibition on the induction of BNIP-3 and BNIP-3L mRNA, and BNIP-3 protein expression levels induced by CoCl2 treatment in HIF-1α siRNA transfected hPSCs (Supplementary Fig. S8a,b). These last results suggest that these pro-apoptotic factors are not involved in chemical hypoxia apoptosis induction. Importantly, we found that in hPSCs an efficient siRNA-mediated downregulation of BNIP-3 was not able to revert the increased apoptosis or necrosis induced by chemical hypoxia (CoCl2 250 µM) as judged by PI staining and Trypan blue dye exclusion data confirming the above finding (Supplementary Fig. S8c, d and e).
Participation of P53 and NOXA on apoptosis triggered by chemical hypoxia
Later, as P53 and NOXA were up-regulated upon CoCl2 (250 µM) treatment in hPSCs, we aimed to study the participation of these two potential pro-apoptotic proteins in hPSCs CoCl2-induced apoptosis regulation by using a siRNA approach. Again, the efficiency of each siRNA- knockdown was first monitored by RT-qPCR and Western blot in H9 hESCs and FN2.1 hiPSCs cultured in defined E8 medium and transfected with either NT-siRNA or specific siRNAs. As shown in Fig. 6a,b, siRNA transfection led to a significant decrease in P53 mRNA and protein expression levels. However, in the case of NOXA, although only a slight downregulation in mRNA expression levels was observed, a strong silencing of its protein levels was found. It could be the case that, as NOXA is a rapid response gene, its fast transcription compensates siRNA-mediated NOXA mRNA downregulation.
Interestingly, we found that in hPSCs siRNA-mediated downregulation of NOXA but not P53 was able to at least partially revert the increased apoptosis or necrosis induced by chemical hypoxia (CoCl2 250 µM) as judged by PI staining and Trypan blue dye exclusion data (Fig. 6c,d). Notably, on the case of P53, a partial but not significant reversion was observed only on the Trypan blue dye exclusion experiments (Fig. 6d).
Finally, we wondered if a similar mechanism was involved in DMOG-induced apoptosis of hPSCs. Similar to what we observed with CoCl2-treatment, P53 and NOXA were up-regulated upon DMOG (1 mM) treatment in hPSCs (Supplementary Fig. S9a). Again, siRNA-mediated downregulation of NOXA but not P53 was able to at least partially revert the increased apoptosis or necrosis induced by chemical hypoxia (DMOG 1 mM) in hPSCs as judged by PI staining and Trypan blue dye exclusion data (Supplementary Fig. S9b,c).
Taken together, the above results suggest that NOXA mediates, at least in part, cell death induction by chemical hypoxia in hPSCs.
hPSCs, as previously mentioned, hold great potential to provide cellular therapy for a range of diseases, being also invaluable sources for the study of human development and disease, as well as for drug discovery. For this challenge to be achieved with safety and efficiency, hPSCs need to be maintained in vitro as highly pluripotent populations in the absence of spontaneous differentiation and with a tight control of cell viability. Accumulating data suggests that environmental in vitro cell culture conditions and specifically O2 tension have an impact on the maintenance of hPSCs proliferation, self-renewal and stemness. Use of low environmental O2 tensions (for example 5%) has been shown to promote self-renewal, to increase expression of key pluripotency markers, to reduce the amount of spontaneous differentiation and to decrease incidence of chromosomal abnormalities and cell death rate9,10,11,25.
Key regulators of the hypoxia response are HIF-1α and HIF-2α. These transcription factors exert a complex role regulating more than 100 genes including glycolytic enzymes and survival factors, which are required to cope with low oxygen tensions. Herein, we explored the effect of stabilizing HIF-1α and HIF-2α with two structurally independent prolyl-hydroxylase inhibitors CoCl2 and DMOG in hPSCs under ambient air. We found that both agents were effective in stabilizing HIF-1α in hESCs and hiPSCs lines. However, in the case of HIF-2α we observed that basal expression levels were not induced upon chemical hypoxia induction. Moreover, CoCl2 and DMOG treatments markedly reduced cell viability as well as induced typical cell death and apoptotic features, like cell shrinkage, ballooning and detachment, chromatin condensation and nuclear fragmentation.
Furthermore, in the present study, we observed an intricate balance between factors that induce or counteract apoptosis during chemical hypoxia stimulation, which finally ended in programmed cell death induction. The main mechanisms of apoptosis are the intrinsic (mitochondrial mediated) and the extrinsic (death receptor mediated) pathways. It has become clear that intrinsic and extrinsic pathways are not mutually exclusive and components of both may co-participate in the regulation of the apoptotic program in response to a single stimulus. Moreover, effector caspases (like CASPASE-3) are key and common executioner proteases in both apoptosis-induction pathways26. In this sense, we showed that CASPASE-3 activity was enhanced in CoCl2- and DMOG-treated hPSCs and may play a key role in chemical induced-apoptosis, which is consistent with previous studies in mESCs and PC12 cells12,27. Besides, based on CASPASE-9 (initiator caspase of the intrinsic pathway) cleavage and activation, we found that intrinsic pathway participates in chemical hypoxia induced-apoptosis in hPSCs. Even more, by an exploratory screening of 43 human apoptosis-related proteins, we also observed changes in extrinsic pathway related proteins (CASPASE-8, TNF-α, sTNF-R2, IGFBP family, FAS and DR6) that indicates that the death receptor mediated apoptosis pathway might also participate in chemical hypoxia induced-apoptosis in hPSCs. Nevertheless, more experiments should be performed in order to confirm this hypothesis. Interestingly, Lee, J. H. et al. achieved similar conclusions in mESCs upon CoCl2 treatment12,28.
HIF-1α, depending on the type and status of the cells and the severity of oxygen deprivation, can prevent cell death, induce apoptosis or even stimulate cell proliferation29. In solid tumors, as an example, severe hypoxia in the presence of energy stimulates cells to undergo apoptosis, whereas oxygen levels above 0.5% prevent cell death29. This could also be the case in hPSCs, which share the predominance of glycolytic metabolism with cancer cells30.
Hypoxia induces apoptosis at least in two ways: by HIF-1α stabilization and by ROS generation29. In fact, HIF-1α, acting in combination with other factors, can either induce or inhibit apoptosis31,32.
Both HIF-1α and HIF-2α play critical roles in regulating responses of different cell types exposed to hypoxic environments. Thus, we wondered whether HIF-1α and HIF-2α were also key mediators of chemical hypoxia-induced apoptosis in hPSCs. HIF-1α can induce apoptosis by P53 stabilization33 or by transcriptional upregulation of pro-apoptotic proteins like BNIP-3 and BNIP-3L15,34,35. However, until the present, the complicated hypoxic cell death pathways cannot be explained only by the induction of these few well-known pro-apoptotic responsive genes. In fact, herein we demonstrated that chemical hypoxia induced P53 (protein levels), BNIP-3 (mRNA and protein levels) and BNIP-3L (mRNA levels). Even though, we found that siRNA-mediated downregulation of HIF-1α and HIF-2α did not significantly affect the extent of cell death triggered by CoCl2 and DMOG in hPSCs, suggesting the participation of alternative pathways. In line with this finding, we demonstrated that siRNA-mediated BNIP-3 gene silencing was also not able to revert apoptosis induction upon CoCl2 treatment. In consequence, these proteins probably are not critical mediators of chemical hypoxia-induced apoptosis in hPSCs. Interestingly, others achieved similar conclusions in a different cellular context36.
As previously mentioned, P53 is a transcription factor that can promote cell survival and adaptation to mild stress as well as induce cell death upon confrontation with severe stress. Importantly, P53 activation by chemical hypoxia was found to be a HIF-1α independent mechanism of apoptosis induction in human lung cells37. In fact, to gain insight into this possible mechanism of chemical hypoxia-induced cell death regulation in hPSCs, we use siRNA methods to reduce P53 expression levels. However, despite the fact that P53 was upregulated in hPSCs exposed to chemical hypoxia its downregulation did not significantly affect the rate of cell death observed in NT-siRNA transfectants, indicating that this transcription factor is not a key player in chemical hypoxia-induced apoptosis in hPSCs.
NOXA, a BH3-only mitochondrial protein that contributes to apoptosis by disrupting mitochondrial outer membrane integrity, is a mediator of P53- and HIF-1α-dependent or -independent cell death that can be transcriptionally activated under hypoxic environments38,39,40,41. Besides, NOXA is highly expressed in hPSCs21 and is responsible for the highly sensitive mitochondrial apoptosis observed in the aforementioned stem cells42. The fact that NOXA was upregulated after CoCl2 and DMOG treatment prompted us to explore its role in the regulation of hPSCs death. To do so, we transfected cells with specific siRNA and found that diminished NOXA levels protected cells from CoCl2 or DMOG induced apoptosis. In this sense, it is well known that CoCl2, can induce cell death through oxidative stress by increasing ROS generation43,44. Recently, it has been reported that the generation of ROS at the endoplasmic reticulum leads to the upregulation of NOXA, through activation of the ATF4 (activating transcription factor 4)/CHOP (C/EBP-homologous protein) axis, and culminates in cell death45,46,47. Thus, considering that neither the downregulation of HIF-1α or HIF-2α nor the one of P53 protected hPSCs from chemical hypoxia-induced cell death, the upregulation of NOXA by ATF4/CHOP cascade, although unproven, could be an alternative pathway that regulates hPSCs fate upon CoCl2 or DMOG exposure (chemical hypoxia and ROS generation).
Finally, therapeutic application of hPSCs-differentiated progenies carries the potential to form teratomas (composed from cells of the three embryonic germ layers), due to the presence of residual undifferentiated cells. Hence, the removal of these contaminating undifferentiated hPSCs has been considered a critical requirement for hPSCs-based clinical applications48. As an example, etoposide treatment of early cardiac progenitors derived from hiPSCs was shown to be effective in eliminating residual hiPSCs thus decreasing the effect of teratoma formation49. In this sense, chemical hypoxia induction, particularly CoCl2 or DMOG treatments, might be a suitable treatment to eliminate potentially teratogenic hPSCs contamination from more resistant differentiated derivatives thus ensuring safer clinical applications. However, it would only be useful on more ROS-resistant or antioxidant-rich differentiated progenies (as human fibroblasts, HF) and right now is only a speculation that requires further investigation.
Cell lines and culture
hESCs line WA09 (H9)1 was purchased from WICELL RESEARCH INSTITUTE (http://www.wicell.org) at low passages (p15 to p20). hiPSCs line FN2.1 were derived from human foreskin fibroblasts (HF) at our laboratory per under relevant guidelines and regulations and has been fully validated50. All experimental protocols where hiPSCs FN2.1 line was used, including derivation, were given ethical approval by the local Ethics Committee (Comité de ética en investigaciones biomédicas del Instituto FLENI) and written informed consent was obtained from donor prior to foreskin fibroblasts isolation. hPSCs were maintained on Vitronectin (0.5 µg/cm2) coated dishes (VTN-N, GIBCO) in combination with fully defined Essential 8 medium (E8, GIBCO). Cultures were split every 3 to 4 days by means of PBS-EDTA (Versene, GIBCO) passaging. Before experiments, hPSCs grown on Vitronectin and E8 were dissociated into single cells using Accutase 1x (GIBCO) for 7 min, plated onto Vitronectin coated dishes (with addition of 10 µM Y-27632 ROCK inhibitor) and grown until confluence with E8. Human foreskin fibroblasts (HF) were prepared as primary cultures from freshly obtained human foreskins as previously described51 after obtaining written informed consent from donor according to guidelines established by the Ethics Committee of FLENI. All cell lines were free of Mycoplasma sp. infection, which was tested as previously described52.
Reagents and hypoxia induction
Cobalt (II) chloride hexahydrate (CoCl2) (SIGMA, C8661) and dimethyloxalylglycine (DMOG) (CALBIOCHEM, 400091) were dissolved in H2O and DMSO, respectively, and stored at − 80 °C protected from light. Reagents were added to cell cultures such that the final concentrations were not higher than 0.10% (v/v). Both CoCl2 and DMOG were used to induce chemical hypoxia in hPSCs. Particularly, CoCl2 is a chelating agent that displace Fe2+ from the active center of prolyl-hydroxylases, inhibiting them and preventing Hypoxia-inducible transcription factor 1α (HIF-1α) degradation13. DMOG also affects the HIF prolyl-hydroxylases, inhibiting them competitively14. The result in both cases is the increase in HIF-1α intracellular levels. Furthermore, 5% O2 cellular hypoxia was achieved using a modular hypoxia incubator chamber (Galaxy CO-14S, EPPENDORF NEW BRUNSWICK).
RNA isolation and RT-qPCR
Total RNA was extracted from hPSCs with TRIzol (THERMO SCIENTIFIC) and cDNA was synthesized from 500 ng of total RNA with 15 mM of random hexamers and MMLV reverse transcriptase (PROMEGA), according to manufacturer's instructions and as previously described18,51. For qPCR studies, cDNA samples were diluted fivefold and PCR amplification and analysis were performed with STEPONEPLUS REAL TIME PCR SYSTEM (PE APPLIED BIOSYSTEMS). The FASTSTART UNIVERSAL SYBR GREEN MASTER MIX (ROX) (ROCHE) was used for all reactions, following manufacturer´s instructions. For information about primers sequences please see Supplementary methods (Table S1).
Protein expression levels were analyzed as previously described18,51,53. Briefly, total proteins were extracted from hPSCs in ice-cold RIPA protein extraction buffer (SIGMA) supplemented with protease inhibitors. Protein concentration was determined using BICINCHONINIC ACID PROTEIN ASSAY (PIERCE). Equal amounts of protein were electrophoresed on a 12% SDS-polyacrylamide gel and transferred to PVDF membranes. Blots were blocked 1 h at RT (room temperature) in TBS (20 mM Tris-HCl, pH 7.5, 500 mM NaCl) containing low-fat powdered milk (5%) and Tween 20 (0.1%). Incubations with primary antibodies were performed ON (overnight) at 4 °C in blocking buffer (3% skim milk, 0.1% Tween, in Tris-buffered saline). Membranes were then incubated with the corresponding counter-antibody and the proteins revealed by enhanced chemiluminescence detection (SUPERSIGNAL WEST FEMTO SYSTEM, THERMO SCIENTIFIC). For information about antibodies used please see Supplementary methods (Table S2). Densitometric analysis of protein levels were performed with IMAGEJ 1.34S SOFTWARE (WAYNE RASBAND, NATIONAL INSTITUTES OF HEALTH, https://imagej.nih.gov/ij/).
Apoptosis protein antibody array membrane analysis
Relative levels of 43 human apoptosis-related proteins (Array Map information available in Supplementary methods, Table S3) were detected and analyzed using the human APOPTOSIS ARRAY KIT (ab134001, ABCAM), following manufacturer´s instructions. Briefly, membranes containing immobilized apoptosis-related antibodies were blocked for 2 h with BSA (bovine serum albumin for) on a rocking platform at RT. Membranes were then incubated with lysates of untreated or CoCl2 (250 µM)-treated H9 hESCs, along with Detection Antibody Cocktail (biotin-conjugated antibodies) ON at 4 °C. Finally, membranes were incubated with Streptavidin horseradish peroxidase conjugates and revealed by chemiluminescence detection. Densitometric analysis of protein levels were performed with IMAGEJ 1.34S SOFTWARE and values normalized against positive control spots following manufacturer´s instructions.
Cell viability assay
hPSCs were plated onto Vitronectin coated 96-well dishes at densities between 1 × 104–3 × 104 cells per well and grown until confluence. 24 h post-treatments, 50 μg/well of activated 2,3-bis (2-methoxy-4-nitro-5-sulfophenyl)-5 [(phenylamino) carbonyl]-2 H-tetrazolium hydroxide (XTT) in PBS containing 0.3 μg/well of N-methyl dibenzopyrazine methyl sulfate (PMS) were added (final volume 100 μl) and incubated for 1–2 h at 37 °C. Cellular metabolic activity was determined spectrophotometrically at 450 nm18,53.
Trypan blue staining
For Trypan blue exclusion assay, hPSCs were seeded on Vitronectin coated 6-well tissue culture plates at a density of 1 × 105 cells/ml. At 24 h post-treatments, adherent and detached cells were collected and stained with 0.4% Trypan blue solution (final concentration 0.08%) for 5 min at room temperature. Cells were counted in a hemocytometer chamber. Percentages of surviving cells (unstained) were calculated as total number of live cells divided by total number of cells (stained) and multiplied by 10018,53.
Flow cytometric analysis of cell viability by Propidium Iodide (PI) staining
Cell viability was analyzed by PI staining as previously described18,53. Briefly, 24 h after treatments, single-cell suspensions were obtained with Accutase (37 °C for 7 min). hPSCs were then centrifuged at 200 × g for 5 min and resuspended up to 1 × 106 cells/ml in FACS Buffer (2.5 mM CaCl2, 140 mM NaCl and 10 mM HEPES pH 7.4). Next, 100 µl of cellular suspension were incubated with 5 µl of PI (50 µg/ml) in PBS for 5 min in the dark. Finally, 400 µl of FACS Buffer were added to each tube and cells were immediately analyzed by flow cytometry. Data was acquired on a BD ACCURI C6 FLOW CYTOMETER and analyzed using BD ACCURI C6 SOFTWARE.
hPSCs were grown on Vitronectin coated MWx24 cell culture dishes with E8 medium and, 24 h post-treatments, rinsed with ice-cold PBS and fixed in PBSA (PBS with 0.1% bovine serum albumin) with 4% formaldehyde for 45 min. After two washes cells were permeabilized with 0.1% Triton X-100 in PBSA with 10% normal goat serum for 30 min, washed twice and stained with stained with 4-6-Diamidino-2-phenylindole (DAPI) for 20 min. Stained cells were examined under a NIKON ECLIPSE TE2000-S inverted microscope equipped with a 20X E-Plan objective and a super high-pressure mercury lamp. The images were acquired with a NIKON DXN1200F digital camera, which was controlled by the ECLIPSENET SOFTWARE (version 1.20.0 build 61)51. Percentages of apoptotic nuclei were calculated as total number of cells showing chromatin condensation divided by total number of cells and multiplied by 100.
Assessment of DNA fragmentation
Apoptosis induction was quantified by direct determination of nucleosomal DNA fragmentation with CELL DEATH DETECTION ELISAPLUS KIT (ROCHE) as previously described18. Briefly, 2 × 105 hPSCs were plated on 24-well culture plates in 500 μl cell culture media. 24 h after chemical hypoxia induction, cells were lysed according to manufacturer's instructions, followed by centrifugation (200 × g, 5 min). The mono and oligonucleosomes in the supernatants were determined using an anti-histone-biotinylated antibody. The resulting color development was measured at 405 nm wavelength using a multiplate spectrophotometer. Results were expressed as DNA oligomer fold induction versus vehicle (DMSO), calculated from the ratio of absorbance of treated samples to that of untreated ones.
Immunostaining and fluorescence microscopy
hPSCs were analyzed for in situ immunofluorescence as previously described51,53. Briefly, cells were rinsed with ice-cold PBS and fixed in PBSA (PBS with 0.1% bovine serum albumin) with 4% formaldehyde for 45 min. After two washes cells were permeabilized with 0.1% Triton X-100 in PBSA with 10% normal goat serum for 30 min, washed twice and stained with a rabbit polyclonal antibody anti-active CASPASE-3 (ab13847, ABCAM). Fluorescent secondary antibody Alexa Fluor 488-conjugated anti-rabbit IgG was purchased from Invitrogen and was used to localize the antigen/primary antibody complexes. Cells were counterstained with DAPI and examined under a NIKON ECLIPSE TE2000-S inverted microscope equipped with a 20X E-Plan objective and a super high-pressure mercury lamp. The images were acquired with a NIKON DXN1200F digital camera, which was controlled by the ECLIPSENET SOFTWARE (version 1.20.0 build 61).
Cell transfection and RNA interference
Cells were transfected with the corresponding small interfering RNA (siRNA) using Lipofectamine RNAiMAX lipid reagent (INVITROGEN) as per manufacturer's instructions and as previously described18,53. Briefly, 2 × 105 cells were plated unicellular on Vitronectin-coated 24-well dishes, grown 24 h with E8 media and then transfected with Silencer Select Negative Control #2 (AMBION, Cat. #4390846) or Silencer Select Validated HIF-1α siRNA (AMBION, Cat. #4390824, siRNA ID: s6539) or Silencer Select Validated EPAS1 (HIF-2α) siRNA (AMBION, Cat. #4390824, siRNA ID: s4699) or Silencer Select Validated BNIP-3 siRNA (AMBION, Cat. #4392420, siRNA ID: s2059) or Silencer Select PMAIP1 (NOXA) siRNA (AMBION, Cat. #4392420, siRNA ID: s10709) or Silencer Validated P53 siRNA (AMBION, Cat. # AM51331, siRNA ID: 106141). The concentration of siRNA used for cell transfection was 20 nM.
Data were analyzed using GRAPHPAD PRISM VERSION 6. All results are expressed as mean ± SEM. One-way ANOVAs followed by Dunnett's multiple comparisons tests or two-tailed Student´s t-test were used to detect significant differences (p < 0.05) among treatments as indicated18.
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
Thomson, J. A. et al. Embryonic stem cell lines derived from human blastocysts. Science 282, 1145–1147 (1998).
Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861–872. https://doi.org/10.1016/j.cell.2007.11.019 (2007).
Klimanskaya, I., Rosenthal, N. & Lanza, R. Derive and conquer: sourcing and differentiating stem cells for therapeutic applications. Nat. Rev. Drug Discov. 7, 131–142. https://doi.org/10.1038/nrd2403 (2008).
Geijsen, N. Primed to perish: heightened mitochondrial priming explains hESC apoptosis sensitivity. Cell Stem Cell 13, 371–372. https://doi.org/10.1016/j.stem.2013.09.011 (2013).
Smith, K. A., Waypa, G. B. & Schumacker, P. T. Redox signaling during hypoxia in mammalian cells. Redox Biol. 13, 228–234. https://doi.org/10.1016/j.redox.2017.05.020 (2017).
Dunwoodie, S. L. The role of hypoxia in development of the Mammalian embryo. Dev. Cell 17, 755–773. https://doi.org/10.1016/j.devcel.2009.11.008 (2009).
Ke, Q. & Costa, M. Hypoxia-inducible factor-1 (HIF-1). Mol. Pharmacol. 70, 1469–1480. https://doi.org/10.1124/mol.106.027029 (2006).
Maxwell, P. H. Hypoxia-inducible factor as a physiological regulator. Exp. Physiol. 90, 791–797. https://doi.org/10.1113/expphysiol.2005.030924 (2005).
Ezashi, T., Das, P. & Roberts, R. M. Low O2 tensions and the prevention of differentiation of hES cells. Proc. Natl. Acad. Sci. U. S. A. 102, 4783–4788. https://doi.org/10.1073/pnas.0501283102 (2005).
Narva, E. et al. Continuous hypoxic culturing of human embryonic stem cells enhances SSEA-3 and MYC levels. PLoS ONE 8, e78847. https://doi.org/10.1371/journal.pone.0078847 (2013).
Covello, K. L. et al. HIF-2alpha regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth. Genes Dev. 20, 557–570 (2006).
Lee, J. H. et al. CoCl2 induces apoptosis through the mitochondria- and death receptor-mediated pathway in the mouse embryonic stem cells. Mol. Cell. Biochem. 379, 133–140. https://doi.org/10.1007/s11010-013-1635-5 (2013).
Triantafyllou, A. et al. Cobalt induces hypoxia-inducible factor-1alpha (HIF-1alpha) in HeLa cells by an iron-independent, but ROS-, PI-3K- and MAPK-dependent mechanism. Free Radic. Res. 40, 847–856. https://doi.org/10.1080/10715760600730810 (2006).
Chan, D. A., Sutphin, P. D., Denko, N. C. & Giaccia, A. J. Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1alpha. J. Biol. Chem. 277, 40112–40117. https://doi.org/10.1074/jbc.M206922200 (2002).
Sowter, H. M., Ratcliffe, P. J., Watson, P., Greenberg, A. H. & Harris, A. L. HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors. Cancer Res. 61, 6669–6673 (2001).
Wang, L. et al. Self-renewal of human embryonic stem cells requires insulin-like growth factor-1 receptor and ERBB2 receptor signaling. Blood 110, 4111–4119. https://doi.org/10.1182/blood-2007-03-082586 (2007).
Armstrong, L. et al. The role of PI3K/AKT, MAPK/ERK and NFkappabeta signalling in the maintenance of human embryonic stem cell pluripotency and viability highlighted by transcriptional profiling and functional analysis. Hum. Mol. Genet. 15, 1894–1913. https://doi.org/10.1093/hmg/ddl112 (2006).
Romorini, L. et al. AKT/GSK3beta signaling pathway is critically involved in human pluripotent stem cell survival. Sci. Rep. 6, 35660. https://doi.org/10.1038/srep35660 (2016).
Liu, J. C. et al. High mitochondrial priming sensitizes hESCs to DNA-damage-induced apoptosis. Cell Stem Cell 13, 483–491. https://doi.org/10.1016/j.stem.2013.07.018 (2013).
Zhang, J. & Ney, P. A. Role of BNIP3 and NIX in cell death, autophagy, and mitophagy. Cell Death Differ. 16, 939–946. https://doi.org/10.1038/cdd.2009.16 (2009).
Madden, D. T., Davila-Kruger, D., Melov, S. & Bredesen, D. E. Human embryonic stem cells express elevated levels of multiple pro-apoptotic BCL-2 family members. PLoS ONE 6, e28530. https://doi.org/10.1371/journal.pone.0028530 (2011).
Huskey, N. E. et al. CDK1 inhibition targets the p53-NOXA-MCL1 axis, selectively kills embryonic stem cells, and prevents teratoma formation. Stem Cell Rep. 4, 374–389. https://doi.org/10.1016/j.stemcr.2015.01.019 (2015).
Vousden, K. H. & Lane, D. P. p53 in health and disease. Nat. Rev. Mol. Cell Biol. 8, 275–283. https://doi.org/10.1038/nrm2147 (2007).
Villunger, A. et al. p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science 302, 1036–1038. https://doi.org/10.1126/science.1090072 (2003).
Christensen, D. R., Calder, P. C. & Houghton, F. D. GLUT3 and PKM2 regulate OCT4 expression and support the hypoxic culture of human embryonic stem cells. Sci. Rep. 5, 17500. https://doi.org/10.1038/srep17500 (2015).
Elmore, S. Apoptosis: a review of programmed cell death. Toxicol. Pathol. 35, 495–516. https://doi.org/10.1080/01926230701320337 (2007).
Zou, W. et al. Involvement of caspase-3 and p38 mitogen-activated protein kinase in cobalt chloride-induced apoptosis in PC12 cells. J. Neurosci. Res. 67, 837–843. https://doi.org/10.1002/jnr.10168 (2002).
Jung, J. Y. & Kim, W. J. Involvement of mitochondrial- and Fas-mediated dual mechanism in CoCl2-induced apoptosis of rat PC12 cells. Neurosci. Lett. 371, 85–90. https://doi.org/10.1016/j.neulet.2004.06.069 (2004).
Greijer, A. E. & van der Wall, E. The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis. J. Clin. Pathol. 57, 1009–1014. https://doi.org/10.1136/jcp.2003.015032 (2004).
Gu, W. et al. Glycolytic metabolism plays a functional role in regulating human pluripotent stem cell state. Cell Stem Cell 19, 476–490. https://doi.org/10.1016/j.stem.2016.08.008 (2016).
Akakura, N. et al. Constitutive expression of hypoxia-inducible factor-1alpha renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation. Cancer Res. 61, 6548–6554 (2001).
Piret, J. P., Mottet, D., Raes, M. & Michiels, C. Is HIF-1alpha a pro- or an anti-apoptotic protein?. Biochem. Pharmacol. 64, 889–892. https://doi.org/10.1016/s0006-2952(02)01155-3 (2002).
Chen, D., Li, M., Luo, J. & Gu, W. Direct interactions between HIF-1 alpha and Mdm2 modulate p53 function. J. Biol. Chem. 278, 13595–13598. https://doi.org/10.1074/jbc.C200694200 (2003).
Boyd, J. M. et al. Adenovirus E1B 19 kDa and Bcl-2 proteins interact with a common set of cellular proteins. Cell 79, 341–351 (1994).
Ma, Z. et al. BNIP3 induces apoptosis and protective autophagy under hypoxia in esophageal squamous cell carcinoma cell lines: BNIP3 regulates cell death. Dis. Esophagus 30, 1–8. https://doi.org/10.1093/dote/dox059 (2017).
Guo, M. et al. Hypoxia-mimetic agents desferrioxamine and cobalt chloride induce leukemic cell apoptosis through different hypoxia-inducible factor-1alpha independent mechanisms. Apoptosis 11, 67–77. https://doi.org/10.1007/s10495-005-3085-3 (2006).
Wong, V. C., Morse, J. L. & Zhitkovich, A. p53 activation by Ni(II) is a HIF-1alpha independent response causing caspases 9/3-mediated apoptosis in human lung cells. Toxicol. Appl. Pharmacol. 269, 233–239. https://doi.org/10.1016/j.taap.2013.03.023 (2013).
Rath, S. et al. Inhibition of histone/lysine acetyltransferase activity kills CoCl2-treated and hypoxia-exposed gastric cancer cells and reduces their invasiveness. Int. J. Biochem. Cell Biol. 82, 28–40. https://doi.org/10.1016/j.biocel.2016.11.014 (2017).
Kim, J. Y., Ahn, H. J., Ryu, J. H., Suk, K. & Park, J. H. BH3-only protein Noxa is a mediator of hypoxic cell death induced by hypoxia-inducible factor 1alpha. J. Exp. Med. 199, 113–124. https://doi.org/10.1084/jem.20030613 (2004).
Sharma, K. et al. p53-independent Noxa induction by cisplatin is regulated by ATF3/ATF4 in head and neck squamous cell carcinoma cells. Mol. Oncol. 12, 788–798. https://doi.org/10.1002/1878-0261.12172 (2018).
Perez-Galan, P. et al. The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status. Blood 107, 257–264. https://doi.org/10.1182/blood-2005-05-2091 (2006).
Zhang, J. et al. Anti-apoptotic mutations desensitize human pluripotent stem cells to mitotic stress and enable aneuploid cell survival. Stem Cell Rep. 12, 557–571. https://doi.org/10.1016/j.stemcr.2019.01.013 (2019).
Battaglia, V. et al. Cobalt induces oxidative stress in isolated liver mitochondria responsible for permeability transition and intrinsic apoptosis in hepatocyte primary cultures. Int. J. Biochem. Cell Biol. 41, 586–594. https://doi.org/10.1016/j.biocel.2008.07.012 (2009).
Ciafre, S. A., Niola, F., Giorda, E., Farace, M. G. & Caporossi, D. CoCl(2)-simulated hypoxia in skeletal muscle cell lines: role of free radicals in gene up-regulation and induction of apoptosis. Free Radic. Res. 41, 391–401. https://doi.org/10.1080/10715760601096799 (2007).
Iurlaro, R. & Munoz-Pinedo, C. Cell death induced by endoplasmic reticulum stress. FEBS J. 283, 2640–2652. https://doi.org/10.1111/febs.13598 (2016).
Verfaillie, T. et al. Pro-apoptotic signaling induced by photo-oxidative ER stress is amplified by Noxa, not Bim. Biochem. Biophys. Res. Commun. 438, 500–506. https://doi.org/10.1016/j.bbrc.2013.07.107 (2013).
Soderquist, R., Pletnev, A. A., Danilov, A. V. & Eastman, A. The putative BH3 mimetic S1 sensitizes leukemia to ABT-737 by increasing reactive oxygen species, inducing endoplasmic reticulum stress, and upregulating the BH3-only protein NOXA. Apoptosis 19, 201–209. https://doi.org/10.1007/s10495-013-0910-y (2014).
Blum, B. & Benvenisty, N. The tumorigenicity of human embryonic stem cells. Adv. Cancer Res. 100, 133–158. https://doi.org/10.1016/S0065-230X(08)00005-5 (2008).
Wyles, S. P. et al. Inhibition of DNA topoisomerase II selectively reduces the threat of tumorigenicity following induced pluripotent stem cell-based myocardial therapy. Stem Cells Dev. 23, 2274–2282. https://doi.org/10.1089/scd.2014.0259 (2014).
50Questa, M. et al. Generation of iPSC line iPSC-FH2.1 in hypoxic conditions from human foreskin fibroblasts. Stem Cell Res 16, 300–303, doi:https://doi.org/10.1016/j.scr.2015.12.026 (2016).
Rodriguez Varela, M. S. et al. Regulation of cyclin E1 expression in human pluripotent stem cells and derived neural progeny. Cell Cycle 17, 1721–1744. https://doi.org/10.1080/15384101.2018.1496740 (2018).
Romorini, L. et al. Effect of antibiotics against Mycoplasma sp. on human embryonic stem cells undifferentiated status, pluripotency, cell viability and growth. PLoS ONE 8, e70267. https://doi.org/10.1371/journal.pone.0070267 (2013).
Videla-Richardson, G. A. et al. Human embryonic stem cells display a pronounced sensitivity to the cyclin dependent kinase inhibitor Roscovitine. BMC Mol. Cell Biol. 20, 40. https://doi.org/10.1186/s12860-019-0222-3 (2019).
This work was supported by grants from ANPCyT PID-2014-0052, CONICET PIP112-20150100723CO, Fundación Florencio Fiorini and Fundación FLENI. The authors would like to thank Damián Darío Fernandez Espinosa and Marcela Cañari for their skillful assistance.
The authors declare no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Isaja, L., Mucci, S., Vera, J. et al. Chemical hypoxia induces apoptosis of human pluripotent stem cells by a NOXA-mediated HIF-1α and HIF-2α independent mechanism. Sci Rep 10, 20653 (2020). https://doi.org/10.1038/s41598-020-77792-7